Alessandro Cucchetti, Alessandro Vitale, Matteo Cescon, Martina Gambato, Lorenzo Maroni, Matteo Ravaioli, Giorgio Ercolani, Patrizia Burra, Umberto Cillo, Antonio D. Pinna – 26 October 2013 – Liver transplantation (LT) represents the only chance of long‐term survival for patients with end‐stage liver disease. When the mortality rate for transplant patients returns to the same level as that for the general population, they can be considered statistically cured. However, cure models in the setting of LT have never been applied.

Nicolas Goossens, Francesco Negro – 24 October 2013 – Genotype 3 of the hepatitis C virus (HCV) has been long considered an easy‐to‐treat infection, with higher cure rates (∼70%) than other viral genotypes with the standard combination of pegylated interferon‐α and ribavirin. However, the relative insensitivity of this genotype to most protease inhibitors and the recent unexpected data on decreased effectiveness of sofosbuvir have raised questions on how to achieve universal cure, a goal that seems reasonable for other genotypes.

Nicolas Goossens, Francesco Negro – 24 October 2013 – Genotype 3 of the hepatitis C virus (HCV) has been long considered an easy‐to‐treat infection, with higher cure rates (∼70%) than other viral genotypes with the standard combination of pegylated interferon‐α and ribavirin. However, the relative insensitivity of this genotype to most protease inhibitors and the recent unexpected data on decreased effectiveness of sofosbuvir have raised questions on how to achieve universal cure, a goal that seems reasonable for other genotypes.

Sue V. McDiarmid – 24 October 2013

Sith Siramolpiwat, Susana Seijo, Rosa Miquel, Annalisa Berzigotti, Angeles Garcia‐Criado, Anna Darnell, Fanny Turon, Virginia Hernandez‐Gea, Jaume Bosch, Juan Carlos Garcia‐Pagán – 23 October 2013 – Idiopathic portal hypertension (IPH) is a rare cause of intrahepatic portal hypertension. Data on natural history and prognosis of IPH are limited. We sought to describe the complications and long‐tem outcome of IPH by retrospectively studying 69 biopsy‐proven cases of IPH. Mean duration of follow‐up was 6.7 ± 4.6 years.

Sith Siramolpiwat, Susana Seijo, Rosa Miquel, Annalisa Berzigotti, Angeles Garcia‐Criado, Anna Darnell, Fanny Turon, Virginia Hernandez‐Gea, Jaume Bosch, Juan Carlos Garcia‐Pagán – 23 October 2013 – Idiopathic portal hypertension (IPH) is a rare cause of intrahepatic portal hypertension. Data on natural history and prognosis of IPH are limited. We sought to describe the complications and long‐tem outcome of IPH by retrospectively studying 69 biopsy‐proven cases of IPH. Mean duration of follow‐up was 6.7 ± 4.6 years.

Stuart C Gordon, Eduardo Bruno Martins, Leland J. Yee – 21 October 2013

Darragh Duffy, Rasha Mamdouh, Melissa Laird, Charlotte Soneson, Lenaig Le Fouler, Maï El‐Daly, Armanda Casrouge, Jérémie Decalf, Amal Abbas, Noha Sharaf Eldin, Magnus Fontes, Mohamed Abdel‐Hamid, Mostafa K. Mohamed, Mona Rafik, Arnaud Fontanet, Matthew L. Albert – 21 October 2013 – Viral hepatitis is the leading cause of liver disease worldwide and can be caused by several agents, including hepatitis A (HAV), B (HBV), and C (HCV) virus.

Andrea Lisotti, Francesco Azzaroli, Marco Montagnani, Giuseppe Mazzella – 21 October 2013

Gin‐Ho Lo – 21 October 2013